Low malignant epithelioid peritoneal mesothelioma: Successful treatment with surgical therapy alone

Hepato-Gastroenterology

Volumn 49, Issue 44, 2002, Pages 366-370

  Schmidt, Sven C ^a   Weidemann, H ^a   Muller K M ^a   Krismann, M ^a   Langrehr, J M ^a   Neuhaus, P ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Low malignant epitheloid mesothelioma; Surgical therapy

Indexed keywords

ASBESTOS; CA 125 ANTIGEN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; MALIGNANT MESOTHELIOMA; PERITONEUM MESOTHELIOMA; POSTOPERATIVE CARE; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; BLOOD; COMORBIDITY; INGUINAL HERNIA; MESOTHELIOMA; PERITONEUM TUMOR;

ADULT; CA-125 ANTIGEN; CASE REPORT; COMORBIDITY; HERNIA, INGUINAL; HUMAN; MALE; MESOTHELIOMA; PERITONEAL NEOPLASMS; HUMANS;

EID: 0036016480     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Malignant mesothelioma: Diagnostic and management strategies for 1992
2. Projections of asbestos-related disease 1980-2009
3. Diffuse malignant mesothelioma
4. Survival patterns for malignant mesothelioma
5. Long-term survival in peritoneal mesothelioma. The role of radiotherapy and combined modality treatment
6. Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma
7. Multimodality therapy for malignant mesothelioma based on a study of natural history
8. A malignant tumor arising from the endothelium of the peritoneum and producing a mucoid ascitis fluid
9. Malignant peritoneal mesothelioma: Review of 25 patients
10. New strategies are needed in diffuse malignant mesothelioma
11. Mesotheliome. Pathologie, pathogenese, mesotheliomregister
12. Asbestos fiber content and mesothelioma cell type, site and survival
13. Pathology of malignant mesothelioma
14. Malignant mesothelioma after remote abdominal radiation
15. Malignant peritoneal mesothelioma after cholangiography with thorotrast
16. Diffuse malignant mesothelioma. Prospective evaluation of 69 patients
17. Peritoneal malignant mesothelioma in a patient with recurrent peritonitis
18. Presence of Simian Virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations
19. Peritoneal mesothelioma
20. Hyponatriemia and mesothelioma
21. Mesothelioma: Short latent period after industrial asbestos exposure and prolonged survival
22. Tumor ACTH concentrations in ectopic ACTH syndrome and in control tissues
23. Mesenchymal tumors associated with hypoglycemia: A case report and review of the literature
24. Primary malignant peritoneal mesothelioma. A report of seven cases and a review of the literature
25. Importance of serum CA 125 levels in malignant peritoneal mesothelioma
26. Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma
27. Diffuse malignant mesothelioma
28. Malignant peritoneal mesothelioma: Marked varibiality of CT findings
29. Static DNA cytometry as a diagnostic aid in effusion cytology: I. DNA aneuploidy for identification and differentiation of primary and secundary tumors of the serous membranes
30. Laparoscopic management of cancer patients
31. Peritoneal mesothelioma
32. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura: Experimence with 29 patients
33. Malignant mesothelioma: Prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Womens hospital experience over two decades
34. Peritoneal mesothelioma: Treatment approach based on natural history
35. Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma
36. Treatment of primary peritoneal mesothelioma by continous hyperthermic peritoneal perfusion (CHHP)